Literature DB >> 10431944

The short-term effects of a hostility-reduction intervention on male coronary heart disease patients.

Y Gidron1, K Davidson, I Bata.   

Abstract

This preliminary study examined the effects of a hostility-reduction intervention on patients with coronary heart disease (CHD). Twenty-two high-hostile CHD men were matched on age and hostility and then randomly assigned to a hostility intervention (N = 10) or an information-control group (N = 12). Patients were reassessed immediately and 2 months posttreatment on hostility (with self-report and structured interview) and resting blood pressure. The intervention's overall effect size was moderately strong (d' = .62). Intervention patients reported at both reassessments and were observed at follow-up to be less hostile than controls. At follow-up, intervention patients had significantly lower diastolic blood pressure (DBP) than controls. Finally, reductions in hostility were significantly and positively correlated with reductions in DBP. Replication with a larger sample and CHD outcomes is recommended.

Entities:  

Mesh:

Year:  1999        PMID: 10431944     DOI: 10.1037//0278-6133.18.4.416

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  27 in total

1.  Video-based coping skills to reduce health risk and improve psychological and physical well-being in Alzheimer's disease family caregivers.

Authors:  Virginia P Williams; Lauren Bishop-Fitzpatrick; James D Lane; Lisa P Gwyther; Edna L Ballard; Analise P Vendittelli; Tiffany C Hutchins; Redford B Williams
Journal:  Psychosom Med       Date:  2010-10-26       Impact factor: 4.312

Review 2.  Behavioral interventions in patients with an implantable cardioverter defibrillator: lessons learned and where to go from here?

Authors:  Mirela Habibović; Matthew M Burg; Susanne S Pedersen
Journal:  Pacing Clin Electrophysiol       Date:  2013-02-25       Impact factor: 1.976

3.  Increasing constructive anger verbal behavior decreases resting blood pressure: a secondary analysis of a randomized controlled hostility intervention.

Authors:  K Davidson; M W Macgregor; J Stuhr; Y Gidron
Journal:  Int J Behav Med       Date:  1999

4.  Development and cross-cultural and clinical validation of a brief comprehensive scale for assessing hostility in medical settings.

Authors:  Y Gidron; K Davidson; R Ilia
Journal:  J Behav Med       Date:  2001-02

5.  Rationale and design of a randomized clinical trial comparing stress reduction treatment to usual cardiac care: the Reducing Vulnerability to Implantable Cardioverter Defibrillator Shock-Treated Ventricular Arrhythmias (RISTA) trial.

Authors:  Rebecca G Donahue; Rachel Lampert; Ellen Dornelas; Lynn Clemow; Matthew M Burg
Journal:  Psychosom Med       Date:  2009-12-22       Impact factor: 4.312

6.  Citalopram intervention for hostility: results of a randomized clinical trial.

Authors:  Thomas W Kamarck; Roger F Haskett; Matthew Muldoon; Janine D Flory; Barbara Anderson; Robert Bies; Bruce Pollock; Stephen B Manuck
Journal:  J Consult Clin Psychol       Date:  2009-02

7.  Understanding conscientiousness across the life course: an economic perspective.

Authors:  Gabriella Conti; James J Heckman
Journal:  Dev Psychol       Date:  2014-05

8.  Hostility and smoking cessation treatment outcome in heavy social drinkers.

Authors:  Christopher W Kahler; Nichea S Spillane; Adam M Leventhal; David R Strong; Richard A Brown; Peter M Monti
Journal:  Psychol Addict Behav       Date:  2009-03

9.  Hostility, cigarette smoking, and responses to a lab-based social stressor.

Authors:  Christopher W Kahler; Adam M Leventhal; Suzanne M Colby; Chad J Gwaltney; Thomas W Kamarck; Peter M Monti
Journal:  Exp Clin Psychopharmacol       Date:  2009-12       Impact factor: 3.157

10.  IMPACT OF WILLIAMS LIFESKILLS® TRAINING ON ANGER, ANXIETY AND AMBULATORY BLOOD PRESSURE IN ADOLESCENTS.

Authors:  Vernon A Barnes; Maribeth H Johnson; Redford B Williams; Virginia P Williams
Journal:  Transl Behav Med       Date:  2012-08-30       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.